Ausgabe 3/2011
Inhalt (36 Artikel)
Heating cancer stem cells to reduce tumor relapse
Pier Giuseppe Pelicci, Paola Dalton, Roberto Orecchia
Interpreting breast international group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer
Meredith M Regan, Karen N Price, Anita Giobbie-Hurder, Beat Thürlimann, Richard D Gelber
From bone to breast and back - the bone cytokine RANKL and breast cancer
Lorenz C Hofbauer, Tilman D Rachner, Christine Hamann
Jekyll or Hyde: does Matrigel provide a more or less physiological environment in mammary repopulating assays?
François Vaillant, Geoffrey J Lindeman, Jane E Visvader
Who is in the driver's seat in 8p12 amplifications? ZNF703 in luminal B breast tumors
Alexey V Bazarov, Paul Yaswen
Notch signaling as a therapeutic target for breast cancer treatment?
Jianxun Han, Michael J Hendzel, Joan Allalunis-Turner
Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition
Naoko Takebe, Ronald Q Warren, S Percy Ivy
EZH2-mediated epigenetic repression of DNA repair in promoting breast tumor initiating cells
Olafur Andri Stefansson, Manel Esteller
Coffee consumption modifies risk of estrogen-receptor negative breast cancer
Jingmei Li, Petra Seibold, Jenny Chang-Claude, Dieter Flesch-Janys, Jianjun Liu, Kamila Czene, Keith Humphreys, Per Hall
Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II
A Heather Eliassen, Donna Spiegelman, Bruce W Hollis, Ronald L Horst, Walter C Willett, Susan E Hankinson
Optimal tumor sampling for immunostaining of biomarkers in breast carcinoma
Juliana Tolles, Yalai Bai, Maria Baquero, Lyndsay N Harris, David L Rimm, Annette M Molinaro
Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes
Yinghui Zhang, Marja Moerkens, Sreenivasa Ramaiahgari, Hans de Bont, Leo Price, John Meerman, Bob van de Water
Geminin overexpression prevents the completion of topoisomerase IIα chromosome decatenation, leading to aneuploidy in human mammary epithelial cells
Lauren Gardner, Rohit Malik, Yoshiko Shimizu, Nicole Mullins, Wael M ElShamy
Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silicobased mechanism
Gloria Fuentes, Maurizio Scaltriti, José Baselga, Chandra S Verma
Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study
Jennifer L Patnaik, Tim Byers, Carolyn DiGuiseppi, Dana Dabelea, Thomas D Denberg
Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome
Lingeng Lu, Chong Zhang, Gongjian Zhu, Melinda Irwin, Harvey Risch, Guido Menato, Marco Mitidieri, Dionyssios Katsaros, Herbert Yu
Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study
Kristine H Allin, Børge G Nordestgaard, Henrik Flyger, Stig E Bojesen
NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications
Anthony G Clementz, Allison Rogowski, Kinnari Pandya, Lucio Miele, Clodia Osipo
Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction
Pierre-Emmanuel Colombo, Fernanda Milanezi, Britta Weigelt, Jorge S Reis-Filho
Erratum to: Functional magnetic resonance: biomarkers of response in breast cancer
Elizabeth AM O'Flynn, Nandita M deSouza
Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes
Michael L Gatza, Hsiu-Ni Kung, Kimberly L Blackwell, Mark W Dewhirst, Jeffrey R Marks, Jen-Tsan Chi
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
Mario Giuliano, Antonio Giordano, Summer Jackson, Kenneth R Hess, Ugo De Giorgi, Michal Mego, Beverly C Handy, Naoto T Ueno, Ricardo H Alvarez, Michelino De Laurentiis, Sabino De Placido, Vicente Valero, Gabriel N Hortobagyi, James M Reuben, Massimo Cristofanilli
Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11gene expression in forming surface P-selectin ligands in aggressive breast cancer cells
Craig A Cooney, Fariba Jousheghany, Aiwei Yao-Borengasser, Bounleut Phanavanh, Tina Gomes, Ann Marie Kieber-Emmons, Eric R Siegel, Larry J Suva, Soldano Ferrone, Thomas Kieber-Emmons, Behjatolah Monzavi-Karbassi
Impact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer
Sumit Parmar, Julia Carolin Stingl, Ariana Huber-Wechselberger, Alexander Kainz, Wilfried Renner, Uwe Langsenlehner, Peter Krippl, Jürgen Brockmöller, Elisabeth Haschke-Becher
Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients
Galatea Kallergi, Maria A Papadaki, Eleni Politaki, Dimitris Mavroudis, Vassilis Georgoulias, Sophia Agelaki
Reversal of endocrine resistance in breast cancer: interrelationships among 14-3-3ζ, FOXM1, and a gene signature associated with mitosis
Anna Bergamaschi, Barbara L Christensen, Benita S Katzenellenbogen
Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells
Terry J Shackleford, Qingxiu Zhang, Ling Tian, Thuy T Vu, Anita L Korapati, Angela M Baumgartner, Xiao-Feng Le, Warren S Liao, Francois X Claret
Impact of established prognostic factors and molecular subtype in very young breast cancer patients: pooled analysis of four EORTC randomized controlled trials
Jos A van der Hage, J Sven D Mieog, Cornelis JH van de Velde, Hein Putter, Harry Bartelink, Marc J van de Vijver
The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients
Timothy J Molloy, Astrid J Bosma, Lars O Baumbusch, Marit Synnestvedt, Elin Borgen, Hege Giercksky Russnes, Ellen Schlichting, Laura J van't Veer, Bjørn Naume
Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3
Yasuo Kodera, Yasufumi Katanasaka, Yuka Kitamura, Hitoshi Tsuda, Kazuto Nishio, Tomohide Tamura, Fumiaki Koizumi
Roscovitine confers tumor suppressive effect on therapy-resistant breast tumor cells
Binoj C Nair, Sreeram Vallabhaneni, Rajeshwar R Tekmal, Ratna K Vadlamudi
Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse
Emmanouil Saloustros, Maria Perraki, Stella Apostolaki, Galatea Kallergi, Alexandros Xyrafas, Kostas Kalbakis, Sophia Agelaki, Antonia Kalykaki, Vassilis Georgoulias, Dimitris Mavroudis